CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $48,000 | -91.4% | 30,863 | -90.2% | 0.01% | -93.6% |
| Q1 2021 | $559,000 | +507.6% | 314,000 | +254.0% | 0.11% | +678.6% |
| Q3 2020 | $92,000 | -88.7% | 88,711 | -93.4% | 0.01% | -95.9% |
| Q1 2020 | $813,000 | +27.0% | 1,354,275 | +60.2% | 0.34% | -2.0% |
| Q3 2019 | $640,000 | +2106.9% | 845,432 | +2914.6% | 0.34% | +5650.0% |
| Q4 2018 | $29,000 | +45.0% | 28,045 | +142.5% | 0.01% | +100.0% |
| Q3 2018 | $20,000 | -97.9% | 11,564 | -97.2% | 0.00% | -97.9% |
| Q2 2018 | $937,000 | -76.4% | 407,180 | -68.2% | 0.14% | -38.8% |
| Q1 2018 | $3,976,000 | +384.9% | 1,282,402 | +510.3% | 0.24% | +216.0% |
| Q4 2017 | $820,000 | – | 210,131 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 135,508 | $472,000 | 0.15% |
| Wealth Advisory Solutions, LLC | 156,850 | $546,000 | 0.13% |
| Horst & Graben Wealth Management LLC | 75,722 | $264,000 | 0.07% |
| Miller Investment Management, LP | 50,000 | $174,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 44,655 | $155,000 | 0.02% |
| Triton Wealth Management, PLLC | 13,100 | $24,000 | 0.01% |
| Renaissance Technologies | 1,898,351 | $6,606,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 19,000 | $66,000 | 0.01% |
| Virtu Financial LLC | 19,713 | $69,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 47,265 | $164,000 | 0.01% |